Table 1 Baseline clinical characteristics.

From: Five-year outcomes in patients with multivessel coronary artery disease undergoing surgery or percutaneous intervention

Characteristics

Overall (1035)

CABG (356)

PCI (679)

P value

Preprocedural

 Age, years; mean (SD)

68.2 (9.9)

66.9 (9.2)

68.9 (10.1)

 < 0.01

 Gender, male; n (%)

784 (75.7)

289 (81.2)

495 (72.9)

 < 0.01

 BMI, kg/m2; mean (SD)

28.1 (3.6)

28.0 (3.3)

28.1 (3.7)

0.41

 Fraility; n (%)

98 (9.5)

9 (2.5)

89 (13.1)

 < 0.01

 Current smoking; n (%)

197 (19.0)

65 (18.3)

132 (19.4)

0.65

 COPD; n (%)

99 (9.6)

29 (8.1)

70 (10.3)

0.26

 Diabetes; n (%)

317 (30.6)

98 (27.5)

219 (32.3)

0.12

  With insulin; n (%)

105 (10.1)

29 (8.1)

76 (11.2)

0.12

 Hypertension; n (%)

868 (83.9)

291 (81.7)

577 (85.0)

0.18

 Severe PH; n (%)

90 (8.7)

17 (4.8)

73 (10.8)

 < 0.01

 Dyslipidemia; n (%)

840 (81.2)

284 (79.8)

556 (81.9)

0.41

 Heart failure; n (%)

734 (70.9)

236 (66.3)

498 (73.3)

0.02

  LVEF; % (SD)

37.7 (10.6)

39.0 (10.6)

36.9 (10.6)

 < 0.01

  NYHA class III-IV; n (%)

312 (30.1)

95 (26.7)

217 (32.0)

0.08

 CKD; n (%)

270 (26.1)

66 (18.5)

204 (30.0)

 < 0.01

 Atrial fibrillation; n (%)

256 (24.7)

67 (18.8)

189 (27.8)

 < 0.01

 Anemia; n (%)

332 (32.1)

89 (25.0)

243 (35.8)

 < 0.01

 Prior MI; n (%)

507 (49.0)

189 (53.1)

318 (47.0)

0.06

 Prior revascularization; n (%)

399 (38.6)

111 (31.2)

288 (42.4)

 < 0.01

 Prior PCI; n (%)

308 (29.8)

91 (25.6)

217 (32.0)

0.03

 Prior CABG; n (%)

91 (8.8)

20 (5.6)

71 (10.5)

 < 0.01

 CCS class III-IV; n (%)

431 (41.6)

165 (46.3)

266 (39.2)

0.03

 ACS; n (%)

437 (42.2)

152 (42.7)

285 (42.0)

0.82

  STEMI; n (%)

121 (11.7)

3 (0.8)

118 (17.4)

 < 0.01

  Non-STEMI; n (%)

316 (30.5)

149 (41.9)

167 (24.6)

 < 0.01

 Cardiogenic shock on admission; n (%)

33 (3.2)

4 (1.1)

29 (4.3)

0.01

 PAD; n (%)

63 (6.1)

14 (3.9)

49 (7.2)

0.04

 Carotid stenosis; n (%)

111 (10.7)

34 (9.6)

77 (11.3)

0.38

 Prior stroke/TIA; n (%)

86 (8.3)

26 (7.3)

60 (8.8)

0.40

  Ischemic stroke/TIA; n (%)

72 (7.0)

21 (6.0)

51 (7.5)

0.33

  Hemorrage stroke; n (%)

14 (1.4)

5 (1.4)

9 (1.3)

0.92

 Active cancer; n (%)

27 (2.6)

0 (0.0)

27 (4.0)

 < 0.01

 EuroSCORE II, %; mean (SD)

5.3 (3.2)

3.9 (1.2)

6.0 (3.7)

 < 0.01

 STS score, %; mean (SD)

3.4 (1.9)

2.5 (0.8)

3.9 (2.2)

 < 0.01

Procedural

 Complete revascularization; n (%)

630 (60.9)

233 (65.4)

397 (58.5)

0.03

  1. CABG coronary artery bypass grafting, PCI percutaneous coronary intervention, BMI body mass index, ACS acute coronary syndrome, LVEF left ventricle ejection fraction, CCS Canadian Cardiovascular Society, NYHA New York Heart Association, TIA transient ischemic attack, MI myocardial infarction, PAD peripheral artery disease, CKD chronic kidney disease, COPD chronic obstructive pulmonary disease, PH pulmonary hypertension, EuroSCORE II European System for Cardiac Operative Risk Evaluation II, STEMI ST-segment elevation myocardial infarction, STS Society of Thoracic Surgeons score.
Back to article page